SubHero Banner

Jatenzo® (testosterone undecanoate) – New drug approval

March 27, 2019 - The FDA announced the approval of Clarus Therapeutics’ Jatenzo (testosterone undecanoate) capsules for testosterone replacement therapy in adult males for conditions associated with a deficiency or absence of endogenous testosterone, including primary hypogonadism (congenital or acquired) and hypogonadotropic hypogonadism (congenital or acquired).

Download PDF